FDC Drugs: Delhi High Court sets aside ban on Wockhardt's anti-inflammatory drug

Aditi Singh January 7 2019
land acquisition, CIETAC

In one of several challenges to the ban on the manufacture, sale or distribution of 328 Fixed Dose Combination (FDC) drugs in India, the Delhi High Court today set aside the Centre's decision to ban an FDC manufactured by Wockhardt Ltd.

The said FDC is a formulation of Aceclofenac + Paracetamol + Rabeprazol, and is sold under the brand name ‘Ace Proxyvon Tablet 10 T’. The FDC is typically . . .

You need to have an active subscription to view this content.